Fiserv's stock increased over 5% following reports from The Wall Street Journal that the company is in discussions with major U.S. banks, including JPMorgan and Bank of America, to sell its payments infrastructure business that manages debit card transactions. This move could enhance Fiserv's focus on core operations and improve its financial standing.
In contrast, Vertex Pharmaceuticals announced a $10 billion acquisition of Crinetics Pharmaceuticals, aimed at expanding its portfolio in rare hormonal disease treatments. Following the announcement, Vertex's shares fell nearly 1%, while Crinetics' shares surged, roughly doubling in value.
Additionally, First Solar's stock rose nearly 3% after Deutsche Bank upgraded it from neutral to buy, citing potential benefits from a trade policy shift. Meanwhile, semiconductor stocks faced downward pressure, with Micron and Lam Research both dropping 5% after Samsung reported mixed quarterly results, prompting investors to reduce their exposure to the AI sector.
These developments highlight the dynamic nature of the market and the varying investor sentiments across different sectors